Glenmark Pharmaceuticals rose 1.37% to Rs 1,511.40 after the drug maker reported consolidated net profit of Rs 340.27 crore in Q1 FY25, significantly higher from Rs 14.48 crore in Q1 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
